semaglutide and mcas immune reaction to tirzepatide Mast Cell Activation Syndrome (MCAS) can trigger widespread inflammation, allergies, unexplained CagriSema vs Semaglutide: Dual Amylin/GLP-1

University of Oklahoma researcher Elizabeth Wellberg, Ph.D., is the senior author of a review article in The Journal of Clinical Investigation that gathers current research evidence about the effects of GLP-1 drugs, like Ozempic and Zepbound, on cancer risk.

For nearly everyone who qualifies, dependable improvement is possible with semaglutide for weight loss, a proven and accessible solution

16, 2025 A triple-sized weekly dose of Ozempic works better to help people with obesity shed excess pounds without significant side effects, new

Metabolic ResearchGLP1-R demonstrates exceptional glucose-lowering efficacy through glucose-dependent insulin stimulation from pancreatic -cells

How do bariatric surgery and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compare as obesity treatments regarding weight loss, ongoing costs, and health care utilization in a clinical setting

Learn how oral semaglutide affects tolerance, cravings, and safety, and how it compares to naltrexone.